CN115308423B - 用于先兆子痫风险预测、评估或诊断的生物标志物、试剂盒及方法 - Google Patents

用于先兆子痫风险预测、评估或诊断的生物标志物、试剂盒及方法 Download PDF

Info

Publication number
CN115308423B
CN115308423B CN202211232221.2A CN202211232221A CN115308423B CN 115308423 B CN115308423 B CN 115308423B CN 202211232221 A CN202211232221 A CN 202211232221A CN 115308423 B CN115308423 B CN 115308423B
Authority
CN
China
Prior art keywords
preeclampsia
subject
risk
weeks
biomarker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202211232221.2A
Other languages
English (en)
Chinese (zh)
Other versions
CN115308423A (zh
Inventor
陈利民
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin Yunjian Medical Lab Co ltd
Tianjin Yunjian Medical Instrument Co ltd
Original Assignee
Tianjin Yunjian Medical Lab Co ltd
Tianjin Yunjian Medical Instrument Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Yunjian Medical Lab Co ltd, Tianjin Yunjian Medical Instrument Co ltd filed Critical Tianjin Yunjian Medical Lab Co ltd
Priority to CN202211232221.2A priority Critical patent/CN115308423B/zh
Priority to CN202310102479.9A priority patent/CN117867094A/zh
Publication of CN115308423A publication Critical patent/CN115308423A/zh
Application granted granted Critical
Publication of CN115308423B publication Critical patent/CN115308423B/zh
Priority to PCT/CN2023/095230 priority patent/WO2024077957A1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Primary Health Care (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN202211232221.2A 2022-10-10 2022-10-10 用于先兆子痫风险预测、评估或诊断的生物标志物、试剂盒及方法 Active CN115308423B (zh)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CN202211232221.2A CN115308423B (zh) 2022-10-10 2022-10-10 用于先兆子痫风险预测、评估或诊断的生物标志物、试剂盒及方法
CN202310102479.9A CN117867094A (zh) 2022-10-10 2022-10-10 用于先兆子痫风险预测、评估或诊断的生物标志物、试剂盒及方法
PCT/CN2023/095230 WO2024077957A1 (fr) 2022-10-10 2023-05-19 Biomarqueur, kit et procédé de prédiction et d'évaluation du risque de prééclampsie ou de diagnostic de la prééclampsie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202211232221.2A CN115308423B (zh) 2022-10-10 2022-10-10 用于先兆子痫风险预测、评估或诊断的生物标志物、试剂盒及方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN202310102479.9A Division CN117867094A (zh) 2022-10-10 2022-10-10 用于先兆子痫风险预测、评估或诊断的生物标志物、试剂盒及方法

Publications (2)

Publication Number Publication Date
CN115308423A CN115308423A (zh) 2022-11-08
CN115308423B true CN115308423B (zh) 2023-02-10

Family

ID=83868085

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202211232221.2A Active CN115308423B (zh) 2022-10-10 2022-10-10 用于先兆子痫风险预测、评估或诊断的生物标志物、试剂盒及方法
CN202310102479.9A Pending CN117867094A (zh) 2022-10-10 2022-10-10 用于先兆子痫风险预测、评估或诊断的生物标志物、试剂盒及方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202310102479.9A Pending CN117867094A (zh) 2022-10-10 2022-10-10 用于先兆子痫风险预测、评估或诊断的生物标志物、试剂盒及方法

Country Status (2)

Country Link
CN (2) CN115308423B (fr)
WO (1) WO2024077957A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115308423B (zh) * 2022-10-10 2023-02-10 天津云检医疗器械有限公司 用于先兆子痫风险预测、评估或诊断的生物标志物、试剂盒及方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104487593A (zh) * 2012-05-08 2015-04-01 斯坦福大学托管董事会 用于提供先兆子痫评估的方法和组合物
CN113567687A (zh) * 2021-09-26 2021-10-29 天津云检医疗器械有限公司 检测样品中两种生物标志物的表达水平的试剂在制备用于检测子痫前期试剂盒中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011036429A1 (fr) * 2009-09-25 2011-03-31 The University Of Bristol Dépistage du risque de pré-éclampsie
EP2776839B1 (fr) * 2011-11-09 2017-08-30 Roche Diagnostics GmbH Dynamique de taux sflt-1 ou endogline/plgf en tant qu'indicateur pour prééclampsie imminente et/ou syndrome hellp
US20140141456A1 (en) * 2012-08-30 2014-05-22 Ansh Labs, LLC Papp-a2 as a marker for monitoring, predicting and diagnosing preeclampsia
US10054599B2 (en) * 2013-03-12 2018-08-21 Agency For Science, Technology And Research (A*Star) Pre-eclampsia biomarkers
CN107155350A (zh) * 2014-07-30 2017-09-12 马修·库珀 用于诊断、预后和确认先兆子痫的方法与组合物
CN112673259A (zh) * 2018-07-20 2021-04-16 豪夫迈·罗氏有限公司 基于igfbp-7的先兆子痫预测
CN115308423B (zh) * 2022-10-10 2023-02-10 天津云检医疗器械有限公司 用于先兆子痫风险预测、评估或诊断的生物标志物、试剂盒及方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104487593A (zh) * 2012-05-08 2015-04-01 斯坦福大学托管董事会 用于提供先兆子痫评估的方法和组合物
CN113567687A (zh) * 2021-09-26 2021-10-29 天津云检医疗器械有限公司 检测样品中两种生物标志物的表达水平的试剂在制备用于检测子痫前期试剂盒中的应用

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Angiogenic proteins and adipocytokines as markers for prediction of preeclampsia;Hisashi Masuyama等;《Expert Review of Obstetrics & Gynecology》;20140110;第717-725页 *

Also Published As

Publication number Publication date
CN115308423A (zh) 2022-11-08
WO2024077957A9 (fr) 2024-06-20
WO2024077957A1 (fr) 2024-04-18
CN117867094A (zh) 2024-04-12

Similar Documents

Publication Publication Date Title
KR101996123B1 (ko) 특정 시기 내에 임신중독증의 개시를 배제하기 위한 sFlt-1/PlGF 또는 엔도글린/PlGF 비의 적용 수단 및 방법
CN103946709B (zh) 基于l-fabp诊断急性事件后或外科手术后的肾损伤
CN101377492A (zh) 胱抑素c测定试剂盒
JP4523587B2 (ja) Ａ型及びｂ型急性大動脈解離と急性心筋梗塞の鑑別方法及び鑑別用キット
JP4927825B2 (ja) 初期段階の心機能異常を診断または予測するための装置および方法
CN103917875B (zh) SFlt-1或Endoglin/PlGF的比例动态用作危急的先兆子痫和/或HELLP综合征的指示物
CN108613977B (zh) 一种n末端脑钠肽前体检测试剂盒
US20230358764A1 (en) Diagnostic methods for liver disorders
JP2014532887A5 (fr)
CN115308423B (zh) 用于先兆子痫风险预测、评估或诊断的生物标志物、试剂盒及方法
JP4689651B2 (ja) 急性肺塞栓症用生化学マーカー
CN114034872A (zh) 用于阿尔茨海默症早期诊断的试剂盒及其应用
CN114585923A (zh) 脓毒症管理
US20220283157A1 (en) Multiplexed assay kits for evaluation of systemic lupus erythematosus
WO2008100791A1 (fr) Procédés et kits pour le diagnostic d'une drépanocytose
CN105917233A (zh) 产后hellp综合征、产后子痫或产后子痫前期的预测
US20160018413A1 (en) Methods of Prognosing Preeclampsia
CN109324192A (zh) 快速定量检测抗核抗体含量的检测方法
US20080020475A1 (en) Methods and kits for the diagnosis of hypothyroidism
TW202415952A (zh) 用於子癇前症風險預測、評估或診斷的設備、生物標誌物群組及其在製備用於評估子癇前症風險的設備中的用途
CN113817025B (zh) Sle抗原表位多肽在鉴别sle和其他自身免疫疾病中的作用
CN113831401B (zh) 一种sle抗原表位多肽及其在sle诊断中的作用
CN116773825B (zh) 诊断急性川崎病的血液生物标志物和方法
US20240168038A1 (en) Method of determining prognosis of chronic kidney disease
RU2554817C1 (ru) Способ лабораторной диагностики угрозы прерывания беременности

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant